Titers of antibodies against SARS-CoV2 did not decline within four months
On Sept. 1, 2020, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published a study in…
On Sept. 1, 2020, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published a study in…
On Aug. 25, 2020, AstraZeneca announced that the first participants have been dosed in a Phase I trial…
On Aug. 24, 2020, AXIM Biotechnologies announced that it had signed an exclusive limited licensing, manufacturing and distribution…
On Aug. 24, 2020, XBiotech announced that the FDA issued an emergency use authorization (EUA) for COVID-19 Convalescent…
On Aug. 20, 2020, the La Jolla Institute for Immunology (LJI) announced that Erica Ollmann Saphire, Ph.D. had…
On Aug. 19, 2020, Accelerate Diagnostics and BioCheck announced that the FDA had issued an Emergency Use Authorization…
On Aug. 17, 2020, Scientisfic American reported that Costa Rican scientists at the Clodomiro Picado Institute have inoculated…
On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…
On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…
On Aug. 13, 2020, Heat Biologics reported preclinical data for Heat’s gp96-based COVID-19. The data, generated at the…
On Aug. 11, 2020, LabCorpï¾® announced details of a no charge antibody testing program in response to federal…
On Aug. 10, 2020, two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs)…
On Aug. 10, 2020, iBio provided an update on one of its proprietary vaccine candidates being designed to…
On Aug. 5, 2020, AXIM Biotechnologies announced the development, patent filing and Emergency Use Approval (EUA) filing of…
On Aug. 4, 2020, Precipio announced it had completed the internal validation of the U.S. Food and Drug…
On Jul. 30, 2020, Johnson & Johnson announced that its lead vaccine candidate protected against infection with SARS-CoV-2,…
On Jul. 23, 2020, AXIM Biotechnologies announced development of NeuCovixTM, a rapid diagnostic test measuring levels of functional…
On Jul. 22, 20120, Evotec announced that the U.S. Department of Defense (DoD) had awarded its Seattle-based subsidiary,…
On Jul. 22, 2020, University of California at Los Angeles researchers reported that they found. levels of antibodies…
On Jul. 22, 2020, Oragenics announced that the National Institutes of Health created stabilized pre-fusion spike protein (CoV-2…
On Jul. 22, 2020, Evotec announced that the U.S. Department of Defense awarded its Seattle-based subsidiary, Just –…
On Jul. 21, 2020, GlaxoSmithKline and CureVac announced a strategic collaboration agreement for the research, development, manufacturing and…
On Jul. 20, 2020, AstraZeneca announced that Interim results from the ongoing Phase I/II COV001 trial, led by…
On Jul. 20, 2020, interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed…
On Jul. 20, 2020, Luminex announced the FDA had issued an Emergency Use Authorization for the company’s xMAPï¾®…
On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…
On Jul. 15, 2020, scientists at Washington University School of Medicine in St. Louis reported they had joined…
On Jul. 15, 2020, AXIM Biotechnologies announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of…
On Jul. 13, 2020, a team of researchers from Oxford University, the Rosalind Franklin Institute, Diamond Light Source…
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…